Danimer Scientific’s CEO on How Bioplastics Can Help Save the World

by | Apr 14, 2022

Steve Croskrey, CEO of Danimer Scientific (DNMR), shares why bioplastics tech is ready for takeoff and how the company is moving the world toward a carbon negative future.

Danimer CEO Steve Croskrey joins the Boardroom Alpha podcast

The truth about plastic is that it’s cheap and readily available. The problem is that most plastic is single-use and not biodegradable — not good for the environment. For growth investors looking for an emerging technology play on corporate sustainability and the carbon negative movement, our podcast is a great place to start. To get to the bottom of what’s happening in next-gen bioplastics, Boardroom Alpha sat down with Steve Croskrey, CEO of Danimer Scientific (DNMR), a company on the cutting edge of this important technology.

Danimer deSPAC’d from its sponsor Live Oak Acquisition Corp. in December 2020. Since coming out of the gate as a pre-revenue pre-earnings hypergrowth company, DNMR stock has experienced a fairly familiar pattern of take-off followed by downward pressure. Shares are down by more than 90% from an all-time high of $64 back in February 2021, making this is a great time to dig in and get into the ground floor of an exciting growth story.

DNMR: Life as a Hypergrowth deSPAC

Source: Boardroom Alpha.

Here’s the 10,000 foot view: corporations and investors alike are increasingly looking to reduce their environmental impact and improve their ESG profile. With landfills full of plastics that last hundreds of years and businesses seeking alternatives to fossil fuels, industry tailwinds are clearly converging to support increasing demand for biodegradable plastics.

Let’s face it: we haven’t done enough as a society to support the adoption of more sustainable packaging and reduce our carbon footprint. Sure, we can recycle. But that’s only part of the solution. The reality is this: bioplastics currently comprise only 1% of global plastics. Investors looking at this space will quickly see this is a massive addressable market in its earliest innings. But we’re starting to see some positive momentum. Bioplastics technology has advanced exponentially in the past decade and looks like it’s finally ready for commercialization and adoption.

Source: Grandview Research

That’s where Danimer comes in. Based in Bainbridge, Georgia, Danimer a is bioplastics company focused on the development and production of biodegradable plastics. The company is the largest manufacturer of bioplastics made from PHA (polyhydroxyalkanoate, branded as Nodax). PHA is 100% renewable and uses canola oil rather than the usual fossil fuels used to produce conventional plastics. Danimer also manufactures bioplastics from pre-purchased PLA (polylactic acid) obtained from renewable resources.

Companies in the food and beverage industry, like Pepsi (PEP), Nestle (NSRGY) and Bacardi — are looking to Danimer to manufacture compostable snack food packaging, marine degradable water bottles, and alternatives to plastic straws.  Pepsi also announced a second  joint collaboration with Danimer to develop biodegradable film resins that meet the company’s sustainable flexible-packaging requirements. Right now, roughly 50% of Danimer’s current applications for its bioplastics are for straws. That said, over time we expect to see more films and injection molding-type applications which could grow to become more material in 2 to 3 years’ time as customers increasingly view PHA as bioplastic which can be used for diverse applications.

The technology is complicated, but a high level, PHA, which Croskrey endearingly calls “bug fat,” occurs naturally as energy storage inside microorganisms, similar to the fat cells in animals. Danimer uses bacteria to convert vegetable oil to PHA. A key selling point of Danimer’s PHA is that its water soluble. Other bioplastics require industrial composting to break down.

DNMR: Customer Relationships

Source: Danimer Investor presentation

Skeptics say that other biodegradable plastics such as PBS and PBAT are cheaper to produce, but its diffcult to assess any price/manufacturing cost claims given most companies are still in early stages of their manufacturing build. Danimer operates a manufacturing facility in Kentucky, which is a retrofit fermentation plant. The Kentucky facility currently has 20 million lbs of Nodax finished product capacity annually in phase 1 and its phase 2 is expected to be complete this year with 65 million lbs of capacity annually. The entire Kentucky facility is said to be expected to be EBITDA positive in 2022, based on the company’s pre-merger slide deck. Danimer’s second facility in Georgia will bring an additional 125 million lbs of capacity annually.

Danimer’s competition is similarly in early-stage commercialization. These include companies like Origin Materials (ORGN), which makes bioplastics using cellulose (plant based materials), PureCycle (ROCH), and Japanese company Kaneka.

Like many early stage deSPACs, Danimer is mum on its forward financial projections for now. The company’s pre-merger slide deck shows a revenue CAGR of 60% from 2020-2025 and an EBITDA margin of 28% in 2022.

Q4 and 2021 Highlights

Source: Danimer Investor Presentation

Given the company’s ESG orientation, we’d like to see better diversity and inclusion metrics. Also of note: insider selling (insider sales totaling $1.6M of stock over the past 12 months, although these were mostly distributions out of Live Oak to its partners), and overboarding risk. On the recent CFO transition: Michael (Mike) Hajost was appointed CFO in January 2022, succeeding John (Jad) Dowdy, who remains at the company as Senior Vice President, Financial Planning and Analysis.

Diversity and Inclusion Snapshot

Source: Boardroom Alpha
Source: Boardroom Alpha
Source: Boardroom Alpha

Our take: this is a massive opportunity in the early innings of a multi-decade growth cycle. The main question is whether it’s still early to jump in. The primary risk is execution and getting to scale. But with DNMR shares trading at ~$5, the risk/reward looks reasonable here.

Listen to the podcast for more.

<a href="https://www.boardroomalpha.com/author/joanna/" target="_self">Joanna Makris</a>

Joanna Makris

Joanna has been analyzing and investing in emerging technologies for over two decades, having led the Technology, Media, and Telecom research at several global investment banks, including Mizuho Securities and Canaccord Genuity. Navigating stock market volatility since it all began in 2000. Banjo player, artist, and frittata-maker.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – August 2022

In our latest SPAC market review we take a look at August. A spike in DAs has not done enough to move the needle, and SPAC winter continues.

SPAC Market Review – July 2022

Liquidations, cancelled deals, and a dead IPO market highlight Boardroom Alpha’s July 2022 SPAC market review. Read for a full recap.

SPAC Market Review – June 2022

Boardroom Alpha’s June 2022 SPAC market review looks at the latest trends in SPACs, where the market is heading a recap of activity.

SPAC Research & Analysis

SPAC Daily: Tuesday 9/14

Maxpro Acquisition (JMAC) penned the lone SPAC DA of the day, plus the rest of today’s news in the market.

Know Who Drives Return Podcast

Podcast: Westrock Coffee CEO Scott Ford

Join David Drapkin as he speaks to Westrock Coffee CEO Scott Ford. Westrock Coffee is going public company via a $1.1B deal with Riverview Acquisition Corporation (RVAC).

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.